Caution urged on newer anticoagulants

Doctors need to be cautious about prescribing new-generation anticoagulants, experts say, warning there is currently only “limited appreciation” of who should receive the drugs.

In one of the key submissions to the Federal Government’s high-profile review on anticoagulants for atrial fibrillation, leading haematology groups described the arrival of new-generation anticoagulants as a “breakthrough” in patient management.

However, they outlined several concerns about the rollout of the new